Login / Signup

Cost-effectiveness analysis of minimally invasive surgical treatments for benign prostatic hyperplasia: implications for Japan's public healthcare system.

Hisataka AnezakiFumiyasu EndoGeorgia SwanKenta TakashimaSirikan Rojanasarot
Published in: Journal of medical economics (2024)
Driven by lower retreatment and AE rates, WAVE was a cost-effective and cost-saving treatment for moderate-to-severe BPH in Japan compared to PUL, providing better outcomes at lower costs to the healthcare system.
Keyphrases
  • benign prostatic hyperplasia
  • lower urinary tract symptoms
  • minimally invasive
  • healthcare
  • mental health
  • high intensity
  • type diabetes
  • adipose tissue
  • skeletal muscle
  • drug induced
  • replacement therapy